The Urologic Oncology Program at Rutgers Cancer Institute and Robert Wood Johnson University Hospital offers blue light cystoscopy with Cysview® (hexaminolevulinate hydrochloride) to help improve detection of certain bladder cancers. Cysview is an optical imaging agent that makes non-muscle invasive bladder cancer glow bright pink in blue light, enabling urologists to better see and remove tumors with greater accuracy.